NCT02525484View on ClinicalTrials.gov

A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

Pirfenidone

Pirfenidone 801 mg single oral doses will be given either in the form of tablet or capsules under fed or fasted conditions on Days 1, 4, 7 and 10.

Trial Locations (1)

32953

Merritt Island

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02525484 - A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants | Biotech Hunter | Biotech Hunter